-
1
-
-
79957789430
-
Pharmaceutical technologies for enhancing oral bioavailability of poorly soluble drugs
-
Y.S.R. Krishnaiah Pharmaceutical technologies for enhancing oral bioavailability of poorly soluble drugs J. Bioequiv. Availab. 2 2010 28 36
-
(2010)
J. Bioequiv. Availab.
, vol.2
, pp. 28-36
-
-
Krishnaiah, Y.S.R.1
-
2
-
-
41949100244
-
Drug nanoparticles: Formulating poorly water-soluble compounds
-
E.M. Merisko-Liversidge, and G.G. Liversidge Drug nanoparticles: formulating poorly water-soluble compounds Toxicol. Pathol. 36 2008 43 48
-
(2008)
Toxicol. Pathol.
, vol.36
, pp. 43-48
-
-
Merisko-Liversidge, E.M.1
Liversidge, G.G.2
-
3
-
-
42349094203
-
Nanoparticles in medicine: Therapeutic applications and developments
-
L. Zhang, F.X. Gu, J.M. Chan, A.Z. Wang, R.S. Langer, and O.C. Farokhzad Nanoparticles in medicine: therapeutic applications and developments Clin. Pharmacol. Ther. 83 2008 761 769
-
(2008)
Clin. Pharmacol. Ther.
, vol.83
, pp. 761-769
-
-
Zhang, L.1
Gu, F.X.2
Chan, J.M.3
Wang, A.Z.4
Langer, R.S.5
Farokhzad, O.C.6
-
4
-
-
79952311136
-
Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration
-
S. Hirn, M. Semmler-Behnke, C. Schleh, A. Wenk, J. Lipka, M. Schäffler, S. Takenaka, W. Möller, G. Schmid, U. Simon, and W.G. Kreyling Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration Eur. J. Pharm. Biopharm. 77 2011 407 416
-
(2011)
Eur. J. Pharm. Biopharm.
, vol.77
, pp. 407-416
-
-
Hirn, S.1
Semmler-Behnke, M.2
Schleh, C.3
Wenk, A.4
Lipka, J.5
Schäffler, M.6
Takenaka, S.7
Möller, W.8
Schmid, G.9
Simon, U.10
Kreyling, W.G.11
-
5
-
-
51049092308
-
Factors affecting the clearance and biodistribution of polymeric nanoparticles
-
F. Alexis, E. Pridgen, L.K. Molnar, and O.C. Farokhzad Factors affecting the clearance and biodistribution of polymeric nanoparticles Mol. Pharm. 5 2008 505 515
-
(2008)
Mol. Pharm.
, vol.5
, pp. 505-515
-
-
Alexis, F.1
Pridgen, E.2
Molnar, L.K.3
Farokhzad, O.C.4
-
6
-
-
79953035086
-
PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect
-
S. Acharya, and S.K. Sahoo PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect Adv. Drug Deliv. Rev. 63 2011 170 183
-
(2011)
Adv. Drug Deliv. Rev.
, vol.63
, pp. 170-183
-
-
Acharya, S.1
Sahoo, S.K.2
-
7
-
-
77953026762
-
Superparamagnetic iron oxide-loaded poly (lactic acid)-d-α- tocopherol polyethylene glycol 1000 succinate copolymer nanoparticles as MRI contrast agent
-
C. Prashant, M. Dipak, C.-T. Yang, K.-H. Chuang, D. Jun, and S.-S. Feng Superparamagnetic iron oxide-loaded poly (lactic acid)-d-α-tocopherol polyethylene glycol 1000 succinate copolymer nanoparticles as MRI contrast agent Biomaterials 31 2010 5588 5597
-
(2010)
Biomaterials
, vol.31
, pp. 5588-5597
-
-
Prashant, C.1
Dipak, M.2
Yang, C.-T.3
Chuang, K.-H.4
Jun, D.5
Feng, S.-S.6
-
8
-
-
34547901070
-
Parasitic diseases: Liposomes and polymeric nanoparticles versus lipid nanoparticles
-
A.A. Date, M.D. Joshi, and V.B. Patravale Parasitic diseases: Liposomes and polymeric nanoparticles versus lipid nanoparticles Adv. Drug Deliv. Rev. 59 2007 505 521
-
(2007)
Adv. Drug Deliv. Rev.
, vol.59
, pp. 505-521
-
-
Date, A.A.1
Joshi, M.D.2
Patravale, V.B.3
-
9
-
-
78650679616
-
Preparation of new 5-fluorouracil-loaded zein nanoparticles for liver targeting
-
L.F. Lai, and H.X. Guo Preparation of new 5-fluorouracil-loaded zein nanoparticles for liver targeting Int. J. Pharm. 404 2011 317 323
-
(2011)
Int. J. Pharm.
, vol.404
, pp. 317-323
-
-
Lai, L.F.1
Guo, H.X.2
-
10
-
-
49449102923
-
The role of daidzein-loaded sterically stabilized solid lipid nanoparticles in therapy for cardio-cerebrovascular diseases
-
Y. Gao, W. Gu, L. Chen, Z. Xu, and Y. Li The role of daidzein-loaded sterically stabilized solid lipid nanoparticles in therapy for cardio-cerebrovascular diseases Biomaterials 29 2008 4129 4136
-
(2008)
Biomaterials
, vol.29
, pp. 4129-4136
-
-
Gao, Y.1
Gu, W.2
Chen, L.3
Xu, Z.4
Li, Y.5
-
11
-
-
75449107968
-
Drug delivery to the brain using surfactant-coated poly(lactide-co- glycolide) nanoparticles: Influence of the formulation parameters
-
S. Gelperina, O. Maksimenko, A. Khalansky, L. Vanchugova, E. Shipulo, K. Abbasova, R. Berdiev, S. Wohlfart, N. Chepurnova, and J. Kreuter Drug delivery to the brain using surfactant-coated poly(lactide-co-glycolide) nanoparticles: influence of the formulation parameters Eur. J. Pharm. Biopharm. 74 2010 157 163
-
(2010)
Eur. J. Pharm. Biopharm.
, vol.74
, pp. 157-163
-
-
Gelperina, S.1
Maksimenko, O.2
Khalansky, A.3
Vanchugova, L.4
Shipulo, E.5
Abbasova, K.6
Berdiev, R.7
Wohlfart, S.8
Chepurnova, N.9
Kreuter, J.10
-
12
-
-
72449143073
-
Solid lipid nanoparticles as potential tools for gene therapy: In vivo protein expression after intravenous administration
-
A. del Pozo-Rodríguez, D. Delgado, M.Á. Solinís, J.L. Pedraz, E. Echevarría, J.M. Rodríguez, and A.R. Gascón Solid lipid nanoparticles as potential tools for gene therapy: in vivo protein expression after intravenous administration Int. J. Pharm. 385 2010 157 162
-
(2010)
Int. J. Pharm.
, vol.385
, pp. 157-162
-
-
Del Pozo-Rodríguez, A.1
Delgado, D.2
Solinís, M.Á.3
Pedraz, J.L.4
Echevarría, E.5
Rodríguez, J.M.6
Gascón, A.R.7
-
13
-
-
28844488494
-
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
-
D.E. Owens Iii, and N.A. Peppas Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles Int. J. Pharm. 307 2006 93 102
-
(2006)
Int. J. Pharm.
, vol.307
, pp. 93-102
-
-
Owens Iii., D.E.1
Peppas, N.A.2
-
14
-
-
59649097447
-
Lipid nanoparticles for parenteral delivery of actives
-
M.D. Joshi, and R.H. Müller Lipid nanoparticles for parenteral delivery of actives Eur. J. Pharm. Biopharm. 71 2009 161 172
-
(2009)
Eur. J. Pharm. Biopharm.
, vol.71
, pp. 161-172
-
-
Joshi, M.D.1
Müller, R.H.2
-
15
-
-
84866737577
-
Improvement of drug safety by the use of lipid-based nanocarriers
-
S.B. Lim, A. Banerjee, and H. Önyüksel Improvement of drug safety by the use of lipid-based nanocarriers J. Control. Release 163 2012 34 45
-
(2012)
J. Control. Release
, vol.163
, pp. 34-45
-
-
Lim, S.B.1
Banerjee, A.2
Önyüksel, H.3
-
16
-
-
84862682458
-
Safety assessment of nanomaterials: Implications for nanomedicine
-
A.M. Nyström, and B. Fadeel Safety assessment of nanomaterials: implications for nanomedicine J. Control. Release 161 2012 403 408
-
(2012)
J. Control. Release
, vol.161
, pp. 403-408
-
-
Nyström, A.M.1
Fadeel, B.2
-
17
-
-
51049104302
-
Pharmacokinetics and biodistribution of nanoparticles
-
S.-D. Li, and L. Huang Pharmacokinetics and biodistribution of nanoparticles Mol. Pharma. 5 2008 496 504
-
(2008)
Mol. Pharma.
, vol.5
, pp. 496-504
-
-
Li, S.-D.1
Huang, L.2
-
18
-
-
75549087322
-
Size and shape effects in the biodistribution of intravascularly injected particles
-
P. Decuzzi, B. Godin, T. Tanaka, S.Y. Lee, C. Chiappini, X. Liu, and M. Ferrari Size and shape effects in the biodistribution of intravascularly injected particles J. Control. Release 141 2010 320 327
-
(2010)
J. Control. Release
, vol.141
, pp. 320-327
-
-
Decuzzi, P.1
Godin, B.2
Tanaka, T.3
Lee, S.Y.4
Chiappini, C.5
Liu, X.6
Ferrari, M.7
-
19
-
-
0038032150
-
Solid lipid nanoparticles (SLN) for controlled drug delivery-A review of the state of the art
-
R.H. Müller, K. Mäder, and S. Gohla Solid lipid nanoparticles (SLN) for controlled drug delivery-a review of the state of the art Eur. J. Pharm. Biopharm. 50 2000 161 177
-
(2000)
Eur. J. Pharm. Biopharm.
, vol.50
, pp. 161-177
-
-
Müller, R.H.1
Mäder, K.2
Gohla, S.3
-
21
-
-
84919337092
-
-
Institute for Laboratory Animal Research eigth ed., National Academies Press (US), Washington (DC)
-
Institute for Laboratory Animal Research, Animals Guide for the Care and Use of Laboratory Animals, eigth ed., National Academies Press (US), Washington (DC), 2011.
-
(2011)
Animals Guide for the Care and Use of Laboratory Animals
-
-
-
22
-
-
0018127813
-
Bone marrow in male and female rats
-
D. Dekanić Bone marrow in male and female rats Experientia 34 1978 1313 1314
-
(1978)
Experientia
, vol.34
, pp. 1313-1314
-
-
Dekanić, D.1
-
23
-
-
84866737577
-
Improvement of drug safety by the use of lipid-based nanocarriers
-
S.B. Lim, A. Banerjee, and H. Önyüksel Improvement of drug safety by the use of lipid-based nanocarriers J. Control. Release 163 2012 34 45
-
(2012)
J. Control. Release
, vol.163
, pp. 34-45
-
-
Lim, S.B.1
Banerjee, A.2
Önyüksel, H.3
-
24
-
-
10744230753
-
Plasma protein adsorption of Tween 80- and poloxamer 188-stabilized solid lipid nanoparticles
-
T.M. Göppert, and R.H. Müller Plasma protein adsorption of Tween 80- and poloxamer 188-stabilized solid lipid nanoparticles J. Drug Target. 11 2003 225 231
-
(2003)
J. Drug Target.
, vol.11
, pp. 225-231
-
-
Göppert, T.M.1
Müller, R.H.2
-
25
-
-
84858616151
-
Physico-chemical parameters that govern nanoparticles fate also dictate rules for their molecular evolution
-
S. Dufort, L. Sancey, and J.L. Coll Physico-chemical parameters that govern nanoparticles fate also dictate rules for their molecular evolution Adv. Drug Deliv. Rev. 64 2012 179 189
-
(2012)
Adv. Drug Deliv. Rev.
, vol.64
, pp. 179-189
-
-
Dufort, S.1
Sancey, L.2
Coll, J.L.3
-
26
-
-
77952482569
-
Effects of poloxamer 188 on the characteristics of poly(lactide-co- glycolide) nanoparticles
-
J.M. Chae, S.M. Mo, and I.J. Oh Effects of poloxamer 188 on the characteristics of poly(lactide-co-glycolide) nanoparticles J. Nanosci. Nanotechnol. 10 2010 3224 3227
-
(2010)
J. Nanosci. Nanotechnol.
, vol.10
, pp. 3224-3227
-
-
Chae, J.M.1
Mo, S.M.2
Oh, I.J.3
-
27
-
-
79954468694
-
Pegylation of poly(γ-benzyl-l-glutamate) nanoparticles is efficient for avoiding mononuclear phagocyte system capture in rats
-
I. Ozcan, F. Segura-Sánchez, K. Bouchemal, M. Sezak, O. Ozer, T. Güneri, and G. Ponchel Pegylation of poly(γ-benzyl-l-glutamate) nanoparticles is efficient for avoiding mononuclear phagocyte system capture in rats Int. J. Nanomedicine 5 2010 1103 1111
-
(2010)
Int. J. Nanomedicine
, vol.5
, pp. 1103-1111
-
-
Ozcan, I.1
Segura-Sánchez, F.2
Bouchemal, K.3
Sezak, M.4
Ozer, O.5
Güneri, T.6
Ponchel, G.7
-
28
-
-
0343191443
-
'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): Influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption
-
R. Gref, M. Lück, P. Quellec, M. Marchand, E. Dellacherie, S. Harnisch, T. Blunk, and R.H. Müller 'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption Colloids Surf. B: Biointerfaces 18 2000 301 313
-
(2000)
Colloids Surf. B: Biointerfaces
, vol.18
, pp. 301-313
-
-
Gref, R.1
Lück, M.2
Quellec, P.3
Marchand, M.4
Dellacherie, E.5
Harnisch, S.6
Blunk, T.7
Müller, R.H.8
-
29
-
-
0029379537
-
Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system
-
G. Storm, S.O. Belliot, T. Daemen, and D.D. Lasic Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system Adv. Drug Deliv. Rev. 17 1995 31 48
-
(1995)
Adv. Drug Deliv. Rev.
, vol.17
, pp. 31-48
-
-
Storm, G.1
Belliot, S.O.2
Daemen, T.3
Lasic, D.D.4
-
30
-
-
6344251596
-
Novel long-circulating lipid nanocapsules
-
D. Hoarau, P. Delmas, S.x.E. David, Phanie, E. Roux, and J.-C. Leroux Novel long-circulating lipid nanocapsules Pharm. Res. 21 2004 1783 1789
-
(2004)
Pharm. Res.
, vol.21
, pp. 1783-1789
-
-
Hoarau, D.1
Delmas, P.2
David X. S, E.3
Phanie4
Roux, E.5
Leroux, J.-C.6
-
32
-
-
0037269112
-
Interactions of VIP, secretin and PACAP(1-38) with phospholipids: A biological paradox revisited
-
A. Krishnadas, H. Önyüksel, and I. Rubinstein Interactions of VIP, secretin and PACAP(1-38) with phospholipids: a biological paradox revisited Curr. Pharm. Des. 9 2003 1005 1012
-
(2003)
Curr. Pharm. Des.
, vol.9
, pp. 1005-1012
-
-
Krishnadas, A.1
Önyüksel, H.2
Rubinstein, I.3
-
33
-
-
33746881443
-
Human VIP-alpha: A long-acting, biocompatible and biodegradable peptide nanomedicine for essential hypertension
-
H. Önyüksel, S. Séjourné, H. Suzuki, and I. Rubinstein Human VIP-alpha: a long-acting, biocompatible and biodegradable peptide nanomedicine for essential hypertension Peptides 27 2006 2271 2275
-
(2006)
Peptides
, vol.27
, pp. 2271-2275
-
-
Önyüksel, H.1
Séjourné, S.2
Suzuki, H.3
Rubinstein, I.4
-
34
-
-
33646802288
-
Intratracheal and subcutaneous liposomal VIP normalizes arterial pressure in spontaneously hypertensive hamsters
-
I. Rubinstein, H. Ikezaki, and H. Önyüksel Intratracheal and subcutaneous liposomal VIP normalizes arterial pressure in spontaneously hypertensive hamsters Int. J. Pharm. 316 2006 144 147
-
(2006)
Int. J. Pharm.
, vol.316
, pp. 144-147
-
-
Rubinstein, I.1
Ikezaki, H.2
Önyüksel, H.3
-
35
-
-
84862639203
-
Human pancreatic polypeptide in a phospholipid-based micellar formulation
-
A. Banerjee, and H. Önyüksel Human pancreatic polypeptide in a phospholipid-based micellar formulation Pharm. Res. 29 2012 1698 1711
-
(2012)
Pharm. Res.
, vol.29
, pp. 1698-1711
-
-
Banerjee, A.1
Önyüksel, H.2
-
36
-
-
79960703248
-
Micellar nanomedicine of human neuropeptide y
-
A. Kuzmis, S.B. Lim, E. Desai, E. Jeon, B.S. Lee, I. Rubinstein, and H. Önyüksel Micellar nanomedicine of human neuropeptide Y Nanomedicine 7 2011 464 471
-
(2011)
Nanomedicine
, vol.7
, pp. 464-471
-
-
Kuzmis, A.1
Lim, S.B.2
Desai, E.3
Jeon, E.4
Lee, B.S.5
Rubinstein, I.6
Önyüksel, H.7
-
37
-
-
84857040855
-
Dextran-protamine-solid lipid nanoparticles as a non-viral vector for gene therapy: In vitro characterization and in vivo transfection after intravenous administration to mice
-
D. Delgado, A.R. Gascón, A. del Pozo-Rodríguez, E. Echevarria, A.P. Ruíz de Garibay, J.M. Rodríguez, and M.A. Solinís Dextran-protamine-solid lipid nanoparticles as a non-viral vector for gene therapy: in vitro characterization and in vivo transfection after intravenous administration to mice Int. J. Pharm. 425 2012 35 43
-
(2012)
Int. J. Pharm.
, vol.425
, pp. 35-43
-
-
Delgado, D.1
Gascón, A.R.2
Del Pozo-Rodríguez, A.3
Echevarria, E.4
Ruíz De Garibay, A.P.5
Rodríguez, J.M.6
Solinís, M.A.7
-
38
-
-
33646648428
-
Etoposide-incorporated tripalmitin nanoparticles with different surface charge: Formulation, characterization, radiolabeling, and biodistribution studies
-
L. Reddy, R. Sharma, K. Chuttani, A. Mishra, and R. Murthy Etoposide-incorporated tripalmitin nanoparticles with different surface charge: Formulation, characterization, radiolabeling, and biodistribution studies AAPS J. 6 2004 55 64
-
(2004)
AAPS J.
, vol.6
, pp. 55-64
-
-
Reddy, L.1
Sharma, R.2
Chuttani, K.3
Mishra, A.4
Murthy, R.5
-
39
-
-
21744460519
-
Influence of administration route on tumor uptake and biodistribution of etoposide loaded solid lipid nanoparticles in Dalton's lymphoma tumor bearing mice
-
L. Harivardhan Reddy, R.K. Sharma, K. Chuttani, A.K. Mishra, and R.S.R. Murthy Influence of administration route on tumor uptake and biodistribution of etoposide loaded solid lipid nanoparticles in Dalton's lymphoma tumor bearing mice J. Control. Release 105 2005 185 198
-
(2005)
J. Control. Release
, vol.105
, pp. 185-198
-
-
Harivardhan Reddy, L.1
Sharma, R.K.2
Chuttani, K.3
Mishra, A.K.4
Murthy, R.S.R.5
-
40
-
-
84855318960
-
Pharmacokinetics, dosimetry and comparative efficacy of 188Re-liposome and 5-FU in a CT26-luc lung-metastatic mice model
-
L.C. Chen, Y.H. Chen, I.H. Liu, C.L. Ho, W.C. Lee, C.H. Chang, K.L. Lang, G. Ting, T.W. Lee, and J.H. Shien Pharmacokinetics, dosimetry and comparative efficacy of 188Re-liposome and 5-FU in a CT26-luc lung-metastatic mice model Nucl. Med. Biol. 39 2012 35 43
-
(2012)
Nucl. Med. Biol.
, vol.39
, pp. 35-43
-
-
Chen, L.C.1
Chen, Y.H.2
Liu, I.H.3
Ho, C.L.4
Lee, W.C.5
Chang, C.H.6
Lang, K.L.7
Ting, G.8
Lee, T.W.9
Shien, J.H.10
-
41
-
-
79959866972
-
Magnetic brain tumor targeting and biodistribution of long-circulating PEG-modified, cross-linked starch-coated iron oxide nanoparticles
-
A.J. Cole, A.E. David, J. Wang, C.J. Galbán, and V.C. Yang Magnetic brain tumor targeting and biodistribution of long-circulating PEG-modified, cross-linked starch-coated iron oxide nanoparticles Biomaterials 32 2011 6291 6301
-
(2011)
Biomaterials
, vol.32
, pp. 6291-6301
-
-
Cole, A.J.1
David, A.E.2
Wang, J.3
Galbán, C.J.4
Yang, V.C.5
-
43
-
-
77953160273
-
In vivo biodistribution for tumor targeting of 5-fluorouracil (5-FU) loaded N-succinyl-chitosan (Suc-Chi) nanoparticles
-
C. Yan, J. Gu, Y. Guo, and D. Chen In vivo biodistribution for tumor targeting of 5-fluorouracil (5-FU) loaded N-succinyl-chitosan (Suc-Chi) nanoparticles Yakugaku Zasshi. 130 2010 801 804
-
(2010)
Yakugaku Zasshi.
, vol.130
, pp. 801-804
-
-
Yan, C.1
Gu, J.2
Guo, Y.3
Chen, D.4
-
45
-
-
79952008706
-
The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles
-
K. Xiao, Y. Li, J. Luo, J.S. Lee, W. Xiao, A.M. Gonik, R.G. Agarwal, and K.S. Lam The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles Biomaterials 32 2011 3435 3446
-
(2011)
Biomaterials
, vol.32
, pp. 3435-3446
-
-
Xiao, K.1
Li, Y.2
Luo, J.3
Lee, J.S.4
Xiao, W.5
Gonik, A.M.6
Agarwal, R.G.7
Lam, K.S.8
|